Open original FDA record ↗Recall record
- FDA identifier
- Z-1679-2009
- Company in FDA record
- Boston Scientific CRM Corp
- FDA classification date
- Jul 14, 2009
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Lead connection issues or fracture increases probability of inappropriate therapy: Inappropriate shocks, inappropriate anti-tachycardia pacing therapy, or inappropriate inhibition of needed bradycardia pacing therapy.
Source facts
- Action
- Boston Scientific sent an Urgent Medical Device Information letter, dated March 23, 2009, to physicians following implanted devices. The letter described the issue, the rate of occurance and provided Patient Management Recommendations.
- Initiated
- 2009-03-23
- Root cause
- Device Design
- Terminated
- 2012-10-18
- Distribution
- Worldwide distribution: USA, Guam, Puerto Rico, Aruba, Austria, Belgium, Brazil, Canada, Cayman Islands, Colombia, Cyprus, Czech Republic, Denmark, Egypt, Finland, France, Germany, Greece, Hong Kong, Hungary, Ireland, Israel, Italy, Kuwait, Latvia, Lebanon, Luxembourg, Mexico, Netherlands, New Caledonia, Norway, Philippines, Poland, Polynesia, Portugal, Reunion, Russia, Saudi Arabia, Slovakia, South Africa, Spain, Sweden, Switzerland, United Kingdom, and Venezuela.
- Recall number
- Z-1679-2009
- Recall status
- Terminated
- CDRH record ID
- 81060
- FDA classified
- 2009-07-14
- Recall event number
- 51713